ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using
ICI 182780 before surgery may block the uptake of estrogen by the tumor cells and prevent
metastases. It is not yet known if ICI 182780 is effective in preventing breast cancer
metastases.
PURPOSE: Randomized phase III trial to study the effectiveness of ICI 182780 given before
surgery in treating women who have stage I or stage II primary breast cancer.
Phase:
Phase 3
Details
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC